Literature DB >> 33621270

Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.

Septelia Inawati Wanandi, Agus Limanto, Elvira Yunita, Resda Akhra Syahrani, Melva Louisa, Agung Eru Wibowo, Sekar Arumsari.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0240020.].

Entities:  

Year:  2021        PMID： 33621270      PMCID： PMC7901776          DOI： 10.1371/journal.pone.0247694

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


  1 in total

1.  In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.

Authors:  Septelia Inawati Wanandi; Agus Limanto; Elvira Yunita; Resda Akhra Syahrani; Melva Louisa; Agung Eru Wibowo; Sekar Arumsari
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.